{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:47:12Z","timestamp":1794271632125,"version":"4.9.0"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00352291"],"award-info":[{"award-number":["RS-2024-00352291"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2018-NR031048"],"award-info":[{"award-number":["RS-2018-NR031048"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cancer cells undergo extensive metabolic reprogramming to sustain rapid proliferation and adapt to heterogeneous tumour microenvironments. These metabolic alterations are tightly linked to epigenetic regulation, which reshapes gene expression and cellular signalling mechanisms. Among epigenetic regulators, histone deacetylases (HDACs) have emerged as key modulators of cancer metabolic reprogramming. Along with their canonical roles in histone deacetylation, HDACs regulate non-histone substrates, including metabolic enzymes and transcription factors, thereby coordinating transcriptional and metabolic programmes. In this review, we summarize current insights into HDAC-mediated regulation of glucose, lipid and amino acid metabolism in cancer and discuss the metabolic mechanisms underlying the anticancer effects of HDAC inhibitors. Collectively, we propose an integrated framework in which HDACs function as central regulators of cancer metabolic reprogramming. We highlight the limitations of HDAC inhibitor studies and discuss the emerging importance of isoform-specific HDAC functions in reprogramming cancer-specific metabolic dependencies and therapeutic strategies.<\/jats:p>","DOI":"10.1038\/s12276-026-01820-1","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T07:52:30Z","timestamp":1788335550000},"page":"2812-2824","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Histone deacetylases in cancer metabolic reprogramming"],"prefix":"10.1038","volume":"58","author":[{"given":"Yu Hyun","family":"Jeon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeyeong","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Woo","family":"Youn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Wu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Yeon","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3753-4415","authenticated-orcid":false,"given":"So Hee","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"1820_CR1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/npp.2012.112","volume":"38","author":"LD Moore","year":"2013","unstructured":"Moore, L. D., Le, T. & Fan, G. DNA methylation and its basic function. Neuropsychopharmacology 38, 23\u201338 (2013).","journal-title":"Neuropsychopharmacology"},{"key":"1820_CR2","volume":"27","author":"Y Gao","year":"2024","unstructured":"Gao, Y. et al. Crosstalk between metabolic and epigenetic modifications during cell carcinogenesis. iScience 27, 111359 (2024).","journal-title":"iScience"},{"key":"1820_CR3","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nrg.2016.59","volume":"17","author":"CD Allis","year":"2016","unstructured":"Allis, C. D. & Jenuwein, T. The molecular hallmarks of epigenetic control. Nat. Rev. Genet. 17, 487\u2013500 (2016).","journal-title":"Nat. Rev. Genet."},{"key":"1820_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49370-2","volume":"15","author":"T Liebner","year":"2024","unstructured":"Liebner, T. et al. Acetylation of histones and non-histone proteins is not a mere consequence of ongoing transcription. Nat. Commun. 15, 4962 (2024).","journal-title":"Nat. Commun."},{"key":"1820_CR5","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.canlet.2017.01.033","volume":"391","author":"HW Ryu","year":"2017","unstructured":"Ryu, H. W. et al. HDAC6 deacetylates p53 at lysines 381\/382 and differentially coordinates p53-induced apoptosis. Cancer Lett. 391, 162\u2013171 (2017).","journal-title":"Cancer Lett."},{"key":"1820_CR6","volume":"14","author":"JMJ Punnasseril","year":"2025","unstructured":"Punnasseril, J. M. J., Auwal, A., Gopalan, V., Lam, A. K. & Islam, F. Metabolic reprogramming of cancer cells and therapeutics targeting cancer metabolism. Cancer Med. 14, e71244 (2025).","journal-title":"Cancer Med."},{"key":"1820_CR7","volume":"10","author":"S Wang","year":"2023","unstructured":"Wang, S. et al. Epigenetic regulation of hepatic lipid metabolism by DNA methylation. Adv. Sci. 10, e2206068 (2023).","journal-title":"Adv. Sci."},{"key":"1820_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-08057-2","volume":"16","author":"X Peng","year":"2025","unstructured":"Peng, X. et al. Deacetylation of TALDO1 by HDAC6 promotes glycolysis and nasopharyngeal carcinoma progression through a moonlighting function. Cell Death Dis. 16, 743 (2025).","journal-title":"Cell Death Dis."},{"key":"1820_CR9","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1038\/emboj.2010.136","volume":"29","author":"RH Wilting","year":"2010","unstructured":"Wilting, R. H. et al. Overlapping functions of Hdac1 and Hdac2 in cell cycle regulation and haematopoiesis. EMBO J. 29, 2586\u20132597 (2010).","journal-title":"EMBO J."},{"key":"1820_CR10","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189150","volume":"1879","author":"MD Asmamaw","year":"2024","unstructured":"Asmamaw, M. D., He, A., Zhang, L. R., Liu, H. M. & Gao, Y. Histone deacetylase complexes: structure, regulation and function. Biochim. Biophys. Acta Rev. Cancer 1879, 189150 (2024).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"1820_CR11","volume":"70","author":"K Lee","year":"2022","unstructured":"Lee, K., Whedon, S. D., Wang, Z. A. & Cole, P. A. Distinct biochemical properties of the class I histone deacetylase complexes. Curr. Opin. Chem. Biol. 70, 102179 (2022).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"1820_CR12","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1111\/febs.13061","volume":"282","author":"M Parra","year":"2015","unstructured":"Parra, M. Class IIa HDACs \u2014 new insights into their functions in physiology and pathology. FEBS J. 282, 1736\u20131744 (2015).","journal-title":"FEBS J."},{"key":"1820_CR13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/ni.1673","volume":"10","author":"A Villagra","year":"2009","unstructured":"Villagra, A. et al. The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance. Nat. Immunol. 10, 92\u2013100 (2009).","journal-title":"Nat. Immunol."},{"key":"1820_CR14","volume":"13","author":"H Chen","year":"2022","unstructured":"Chen, H., Xie, C., Chen, Q. & Zhuang, S. HDAC11, an emerging therapeutic target for metabolic disorders. Front. Endocrinol. 13, 989305 (2022).","journal-title":"Front. Endocrinol."},{"key":"1820_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03212-3","volume":"11","author":"R Zhang","year":"2020","unstructured":"Zhang, R. et al. HDAC8-dependent deacetylation of PKM2 directs nuclear localization and glycolysis to promote proliferation in hepatocellular carcinoma. Cell Death Dis. 11, 1036 (2020).","journal-title":"Cell Death Dis."},{"key":"1820_CR16","volume":"12","author":"GW Kim","year":"2025","unstructured":"Kim, G. W. et al. HDAC6 and USP9X control glutamine metabolism by stabilizing GS to promote glioblastoma tumorigenesis. Adv. Sci. 12, e2501553 (2025).","journal-title":"Adv. Sci."},{"key":"1820_CR17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1172\/JCI69738","volume":"124","author":"AC West","year":"2014","unstructured":"West, A. C. & Johnstone, R. W. New and emerging HDAC inhibitors for cancer treatment. J. Clin. Invest. 124, 30\u201339 (2014).","journal-title":"J. Clin. Invest."},{"key":"1820_CR18","volume":"15","author":"J Tian","year":"2025","unstructured":"Tian, J. et al. Advances of HDAC inhibitors in tumor therapy: potential applications through immune modulation. Front. Oncol. 15, 1576781 (2025).","journal-title":"Front. Oncol."},{"key":"1820_CR19","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s13238-014-0082-8","volume":"5","author":"P Jiang","year":"2014","unstructured":"Jiang, P., Du, W. & Wu, M. Regulation of the pentose phosphate pathway in cancer. Protein Cell 5, 592\u2013602 (2014).","journal-title":"Protein Cell"},{"key":"1820_CR20","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw5473","volume":"368","author":"B Faubert","year":"2020","unstructured":"Faubert, B., Solmonson, A. & DeBerardinis, R. J. Metabolic reprogramming and cancer progression. Science 368, eaaw5473 (2020).","journal-title":"Science"},{"key":"1820_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.114","volume":"16","author":"BJ Altman","year":"2016","unstructured":"Altman, B. J., Stine, Z. E. & Dang, C. V. From Krebs to clinic: glutamine metabolism to cancer therapy. Nat. Rev. Cancer 16, 749 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"1820_CR22","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1126\/science.1164097","volume":"324","author":"KE Wellen","year":"2009","unstructured":"Wellen, K. E. et al. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324, 1076\u20131080 (2009).","journal-title":"Science"},{"key":"1820_CR23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg, O. On the origin of cancer cells. Science 123, 309\u2013314 (1956).","journal-title":"Science"},{"key":"1820_CR24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.tibs.2016.01.002","volume":"41","author":"KA Olson","year":"2016","unstructured":"Olson, K. A., Schell, J. C. & Rutter, J. Pyruvate and metabolic flexibility: illuminating a path toward selective cancer therapies. Trends Biochem. Sci. 41, 219\u2013230 (2016).","journal-title":"Trends Biochem. Sci."},{"key":"1820_CR25","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/advances\/nmaa174","volume":"12","author":"P Icard","year":"2021","unstructured":"Icard, P. et al. Metabolic strategies for inhibiting cancer development. Adv. Nutr. 12, 1461\u20131480 (2021).","journal-title":"Adv. Nutr."},{"key":"1820_CR26","volume":"16","author":"Q Yuan","year":"2025","unstructured":"Yuan, Q. et al. Prevalence of GLUT1 overexpression in human cancers a systematic review and meta analysis. Discov. Oncol. 16, 1761 (2025).","journal-title":"Discov. Oncol."},{"key":"1820_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-020-01629-4","volume":"39","author":"J Feng","year":"2020","unstructured":"Feng, J. et al. Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma. J. Exp. Clin. Cancer Res. 39, 126 (2020).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1820_CR28","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.tem.2012.06.010","volume":"23","author":"W Luo","year":"2012","unstructured":"Luo, W. & Semenza, G. L. Emerging roles of PKM2 in cell metabolism and cancer progression. Trends Endocrinol. Metab. 23, 560\u2013566 (2012).","journal-title":"Trends Endocrinol. Metab."},{"key":"1820_CR29","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.1158\/1078-0432.CCR-09-0889","volume":"15","author":"CV Dang","year":"2009","unstructured":"Dang, C. V., Le, A. & Gao, P. MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin. Cancer Res. 15, 6479\u20136483 (2009).","journal-title":"Clin. Cancer Res."},{"key":"1820_CR30","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1593\/neo.04430","volume":"7","author":"IF Robey","year":"2005","unstructured":"Robey, I. F., Lien, A. D., Welsh, S. J., Baggett, B. K. & Gillies, R. J. Hypoxia-inducible factor-1\u0251 and the glycolytic phenotype in tumors. Neoplasia 7, 324\u2013330 (2005).","journal-title":"Neoplasia"},{"key":"1820_CR31","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1126863","volume":"312","author":"S Matoba","year":"2006","unstructured":"Matoba, S. et al. p53 regulates mitochondrial respiration. Science 312, 1650\u20131653 (2006).","journal-title":"Science"},{"key":"1820_CR32","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/emboj.2009.405","volume":"29","author":"JY Lee","year":"2010","unstructured":"Lee, J. Y. et al. HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy. EMBO J. 29, 969\u2013980 (2010).","journal-title":"EMBO J."},{"key":"1820_CR33","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tibs.2014.06.005","volume":"39","author":"KC Patra","year":"2014","unstructured":"Patra, K. C. & Hay, N. The pentose phosphate pathway and cancer. Trends Biochem. Sci. 39, 347\u2013354 (2014).","journal-title":"Trends Biochem. Sci."},{"key":"1820_CR34","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41577-020-0406-2","volume":"21","author":"M Certo","year":"2021","unstructured":"Certo, M., Tsai, C. H., Pucino, V., Ho, P. C. & Mauro, C. Lactate modulation of immune responses in inflammatory versus tumour microenvironments. Nat. Rev. Immunol. 21, 151\u2013161 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"1820_CR35","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.molcel.2012.08.033","volume":"48","author":"DR Donohoe","year":"2012","unstructured":"Donohoe, D. R. et al. The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol. Cell 48, 612\u2013626 (2012).","journal-title":"Mol. Cell"},{"key":"1820_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-015-0114-x","volume":"13","author":"W Wagner","year":"2015","unstructured":"Wagner, W., Ciszewski, W. M. & Kania, K. D. L- and D-lactate enhance DNA repair and modulate the resistance of cervical carcinoma cells to anticancer drugs via histone deacetylase inhibition and hydroxycarboxylic acid receptor 1 activation. Cell Commun. Signal. 13, 36 (2015).","journal-title":"Cell Commun. Signal."},{"key":"1820_CR37","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.18632\/oncotarget.27938","volume":"12","author":"TTT Nguyen","year":"2021","unstructured":"Nguyen, T. T. T., Westhoff, M. A., Karpel-Massler, G. & Siegelin, M. D. Targeting super-enhancers reprograms glioblastoma central carbon metabolism. Oncotarget 12, 1309\u20131313 (2021).","journal-title":"Oncotarget"},{"key":"1820_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-019-0332-8","volume":"17","author":"M Zhang","year":"2019","unstructured":"Zhang, M. et al. Low levels of pyruvate induced by a positive feedback loop protects cholangiocarcinoma cells from apoptosis. Cell Commun. Signal. 17, 23 (2019).","journal-title":"Cell Commun. Signal."},{"key":"1820_CR39","volume":"13","author":"W Zhang","year":"2026","unstructured":"Zhang, W. et al. Lactylation-driven therapeutic resistance in cancer: mechanisms and therapeutic opportunities. Genes Dis. 13, 101935 (2026).","journal-title":"Genes Dis."},{"key":"1820_CR40","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.gendis.2022.10.006","volume":"10","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. The function and mechanism of lactate and lactylation in tumor metabolism and microenvironment. Genes Dis. 10, 2029\u20132037 (2023).","journal-title":"Genes Dis."},{"key":"1820_CR41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.110795","volume":"301","author":"GA Nickel","year":"2025","unstructured":"Nickel, G. A. et al. Sirtuin 6 is a histone delactylase. J. Biol. Chem. 301, 110795 (2025).","journal-title":"J. Biol. Chem."},{"key":"1820_CR42","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.110602","volume":"301","author":"MB Gonzatti","year":"2025","unstructured":"Gonzatti, M. B. et al. Class I histone deacetylases catalyze lysine lactylation. J. Biol. Chem. 301, 110602 (2025).","journal-title":"J. Biol. Chem."},{"key":"1820_CR43","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abi6696","volume":"8","author":"C Moreno-Yruela","year":"2022","unstructured":"Moreno-Yruela, C. et al. Class I histone deacetylases (HDAC1-3) are histone lysine delactylases. Sci. Adv. 8, eabi6696 (2022).","journal-title":"Sci. Adv."},{"key":"1820_CR44","volume":"12","author":"X He","year":"2025","unstructured":"He, X. et al. HDAC2-mediated METTL3 delactylation promotes DNA damage repair and chemotherapy resistance in triple-negative breast cancer. Adv. Sci. 12, e2413121 (2025).","journal-title":"Adv. Sci."},{"key":"1820_CR45","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41586-024-07620-9","volume":"631","author":"H Chen","year":"2024","unstructured":"Chen, H. et al. NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance. Nature 631, 663\u2013669 (2024).","journal-title":"Nature"},{"key":"1820_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02511-7","volume":"24","author":"C Ma","year":"2025","unstructured":"Ma, C. et al. RHOA lactylation at oncogenic hotspots promotes oncogenic activity and protein stabilization. Mol. Cancer 24, 311 (2025).","journal-title":"Mol. Cancer"},{"key":"1820_CR47","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4174\/astr.2025.109.3.169","volume":"109","author":"WW Kim","year":"2025","unstructured":"Kim, W. W. et al. The effect of glycolytic enzyme expression and thyroiditis on the aggressiveness of papillary thyroid carcinoma: a retrospective cohort study. Ann. Surg. Treat. Res. 109, 169\u2013184 (2025).","journal-title":"Ann. Surg. Treat. Res."},{"key":"1820_CR48","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0167-4838(99)00119-3","volume":"1432","author":"MA Sirover","year":"1999","unstructured":"Sirover, M. A. New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase. Biochim. Biophys. Acta 1432, 159\u2013184 (1999).","journal-title":"Biochim. Biophys. Acta"},{"key":"1820_CR49","first-page":"1419","volume":"24","author":"IB Appelskog","year":"2004","unstructured":"Appelskog, I. B. et al. Histone deacetylase inhibitor 4-phenylbutyrate suppresses GAPDH mRNA expression in glioma cells. Int. J. Oncol. 24, 1419\u20131425 (2004).","journal-title":"Int. J. Oncol."},{"key":"1820_CR50","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1074\/jbc.M113.531640","volume":"289","author":"T Li","year":"2014","unstructured":"Li, T. et al. Glyceraldehyde-3-phosphate dehydrogenase is activated by lysine 254 acetylation in response to glucose signal. J. Biol. Chem. 289, 3775\u20133785 (2014).","journal-title":"J. Biol. Chem."},{"key":"1820_CR51","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1084\/jem.20101470","volume":"208","author":"A Wolf","year":"2011","unstructured":"Wolf, A. et al. Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme. J. Exp. Med. 208, 313\u2013326 (2011).","journal-title":"J. Exp. Med."},{"key":"1820_CR52","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.exphem.2019.09.023","volume":"78","author":"K Nakajima","year":"2019","unstructured":"Nakajima, K. et al. Glycolytic enzyme hexokinase II is a putative therapeutic target in B-cell malignant lymphoma. Exp. Hematol. 78, 46\u201355.e3 (2019).","journal-title":"Exp. Hematol."},{"key":"1820_CR53","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1182\/bloodadvances.2020003566","volume":"5","author":"AA Mensah","year":"2021","unstructured":"Mensah, A. A. et al. Study of the antilymphoma activity of pracinostat reveals different sensitivities of DLBCL cells to HDAC inhibitors. Blood Adv. 5, 2467\u20132480 (2021).","journal-title":"Blood Adv."},{"key":"1820_CR54","doi-asserted-by":"crossref","first-page":"11252","DOI":"10.18632\/oncotarget.3594","volume":"6","author":"M Wu","year":"2015","unstructured":"Wu, M., Seto, E. & Zhang, J. E2F1 enhances glycolysis through suppressing Sirt6 transcription in cancer cells. Oncotarget 6, 11252\u201311263 (2015).","journal-title":"Oncotarget"},{"key":"1820_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-022-02305-5","volume":"41","author":"S Kwak","year":"2022","unstructured":"Kwak, S. et al. miR-3189-targeted GLUT3 repression by HDAC2 knockdown inhibits glioblastoma tumorigenesis through regulating glucose metabolism and proliferation. J. Exp. Clin. Cancer. Res. 41, 87 (2022).","journal-title":"J. Exp. Clin. Cancer. Res."},{"key":"1820_CR56","volume":"5","author":"Y Zheng","year":"2020","unstructured":"Zheng, Y. et al. Insulin-like growth factor 1-induced enolase 2 deacetylation by HDAC3 promotes metastasis of pancreatic cancer. Signal Transduct. Target. Ther. 5, 53 (2020).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1820_CR57","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.18632\/oncotarget.23327","volume":"9","author":"JW Lee","year":"2018","unstructured":"Lee, J. W. et al. Trichostatin A resistance is facilitated by HIF-1\u0251 acetylation in HeLa human cervical cancer cells under normoxic conditions. Oncotarget 9, 2035\u20132049 (2018).","journal-title":"Oncotarget"},{"key":"1820_CR58","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.canlet.2020.03.007","volume":"478","author":"Y Li","year":"2020","unstructured":"Li, Y. et al. AMPK-dependent phosphorylation of HDAC8 triggers PGM1 expression to promote lung cancer cell survival under glucose starvation. Cancer Lett. 478, 82\u201392 (2020).","journal-title":"Cancer Lett."},{"key":"1820_CR59","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc4897","volume":"7","author":"CM Dowling","year":"2021","unstructured":"Dowling, C. M. et al. Multiple screening approaches reveal HDAC6 as a novel regulator of glycolytic metabolism in triple-negative breast cancer. Sci. Adv. 7, eabc4897 (2021).","journal-title":"Sci. Adv."},{"key":"1820_CR60","volume":"12","author":"X Yan","year":"2021","unstructured":"Yan, X. et al. Sorafenib-induced autophagy promotes glycolysis by upregulating the p62\/HDAC6\/HSP90 axis in hepatocellular carcinoma cells. Front. Pharmacol. 12, 788667 (2021).","journal-title":"Front. Pharmacol."},{"key":"1820_CR61","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s11306-009-0192-0","volume":"6","author":"G Alcarraz-Vizan","year":"2010","unstructured":"Alcarraz-Vizan, G., Boren, J., Lee, W. N. & Cascante, M. Histone deacetylase inhibition results in a common metabolic profile associated with HT29 differentiation. Metabolomics 6, 229\u2013237 (2010).","journal-title":"Metabolomics"},{"key":"1820_CR62","doi-asserted-by":"crossref","first-page":"28329","DOI":"10.18632\/oncotarget.8631","volume":"7","author":"BG Debeb","year":"2016","unstructured":"Debeb, B. G. et al. Histone deacetylase inhibitor-induced cancer stem cells exhibit high pentose phosphate pathway metabolism. Oncotarget 7, 28329\u201328339 (2016).","journal-title":"Oncotarget"},{"key":"1820_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1756-1","volume":"10","author":"C Shan","year":"2019","unstructured":"Shan, C. et al. 4-hydroxyphenylpyruvate dioxygenase promotes lung cancer growth via pentose phosphate pathway (PPP) flux mediated by LKB1-AMPK\/HDAC10\/G6PD axis. Cell Death Dis. 10, 525 (2019).","journal-title":"Cell Death Dis."},{"key":"1820_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13668-3","volume":"11","author":"I Martinez-Reyes","year":"2020","unstructured":"Martinez-Reyes, I. & Chandel, N. S. Mitochondrial TCA cycle metabolites control physiology and disease. Nat. Commun. 11, 102 (2020).","journal-title":"Nat. Commun."},{"key":"1820_CR65","volume":"9","author":"Y Sun","year":"2025","unstructured":"Sun, Y. et al. EPAS1 increases SDHA to inhibit proliferation of multiple myeloma cells by restoring TCA Cycle. NPJ Precis. Oncol. 9, 406 (2025).","journal-title":"NPJ Precis. Oncol."},{"key":"1820_CR66","volume":"6","author":"H Nam","year":"2021","unstructured":"Nam, H. et al. The TGF-\u03b2\/HDAC7 axis suppresses TCA cycle metabolism in renal cancer. JCI Insight 6, e148438 (2021).","journal-title":"JCI Insight"},{"key":"1820_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-61897-6","volume":"16","author":"A Roe","year":"2025","unstructured":"Roe, A. et al. Inhibition of HDAC6 alters fumarate hydratase activity and mitochondrial structure. Nat. Commun. 16, 6923 (2025).","journal-title":"Nat. Commun."},{"key":"1820_CR68","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1158\/1078-0432.CCR-17-3070","volume":"24","author":"TM Ashton","year":"2018","unstructured":"Ashton, T. M., McKenna, W. G., Kunz-Schughart, L. A. & Higgins, G. S. Oxidative phosphorylation as an emerging target in cancer therapy. Clin. Cancer Res. 24, 2482\u20132490 (2018).","journal-title":"Clin. Cancer Res."},{"key":"1820_CR69","volume":"22","author":"AK Abdel-Aziz","year":"2024","unstructured":"Abdel-Aziz, A. K. OXPHOS mediators in acute myeloid leukemia patients: prognostic biomarkers and therapeutic targets for personalized medicine. World J. Surg. Oncol. 22, 298 (2024).","journal-title":"World J. Surg. Oncol."},{"key":"1820_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18954-z","volume":"11","author":"S Valle","year":"2020","unstructured":"Valle, S. et al. Exploiting oxidative phosphorylation to promote the stem and immunoevasive properties of pancreatic cancer stem cells. Nat. Commun. 11, 5265 (2020).","journal-title":"Nat. Commun."},{"key":"1820_CR71","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1007\/s12094-023-03079-8","volume":"25","author":"JD Wang","year":"2023","unstructured":"Wang, J. D., Xu, J. Q., Long, Z. J. & Weng, J. Y. Disruption of mitochondrial oxidative phosphorylation by chidamide eradicates leukemic cells in AML. Clin. Transl. Oncol. 25, 1805\u20131820 (2023).","journal-title":"Clin. Transl. Oncol."},{"key":"1820_CR72","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115283","volume":"205","author":"K Hege Hurrish","year":"2022","unstructured":"Hege Hurrish, K. et al. Co-targeting of HDAC, PI3K, and Bcl-2 results in metabolic and transcriptional reprogramming and decreased mitochondrial function in acute myeloid leukemia. Biochem. Pharmacol. 205, 115283 (2022).","journal-title":"Biochem. Pharmacol."},{"key":"1820_CR73","volume":"298","author":"H Xu","year":"2022","unstructured":"Xu, H. et al. Glucagon changes substrate preference in gluconeogenesis. J. Biol. Chem. 298, 102708 (2022).","journal-title":"J. Biol. Chem."},{"key":"1820_CR74","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.molcel.2015.08.013","volume":"60","author":"EE Vincent","year":"2015","unstructured":"Vincent, E. E. et al. Mitochondrial phosphoenolpyruvate carboxykinase regulates metabolic adaptation and enables glucose-independent tumor growth. Mol. Cell 60, 195\u2013207 (2015).","journal-title":"Mol. Cell"},{"key":"1820_CR75","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119840","volume":"283","author":"P Zhang","year":"2021","unstructured":"Zhang, P., Shao, Y., Quan, F., Liu, L. & Yang, J. FBP1 enhances the radiosensitivity by suppressing glycolysis via the FBXW7\/mTOR axis in nasopharyngeal carcinoma cells. Life Sci. 283, 119840 (2021).","journal-title":"Life Sci."},{"key":"1820_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/srep43864","volume":"7","author":"J Yang","year":"2017","unstructured":"Yang, J. et al. Inhibiting histone deacetylases suppresses glucose metabolism and hepatocellular carcinoma growth by restoring FBP1 expression. Sci. Rep. 7, 43864 (2017).","journal-title":"Sci. Rep."},{"key":"1820_CR77","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bbrc.2010.11.086","volume":"404","author":"H Oiso","year":"2011","unstructured":"Oiso, H. et al. The role of class I histone deacetylase (HDAC) on gluconeogenesis in liver. Biochem. Biophys. Res. Commun. 404, 166\u2013172 (2011).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1820_CR78","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","volume":"168","author":"MG Vander Heiden","year":"2017","unstructured":"Vander Heiden, M. G. & DeBerardinis, R. J. Understanding the intersections between metabolism and cancer biology. Cell 168, 657\u2013669 (2017).","journal-title":"Cell"},{"key":"1820_CR79","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cmet.2015.08.024","volume":"22","author":"SJ Mentch","year":"2015","unstructured":"Mentch, S. J. et al. Histone methylation dynamics and gene regulation occur through the sensing of one-carbon metabolism. Cell Metab. 22, 861\u2013873 (2015).","journal-title":"Cell Metab."},{"key":"1820_CR80","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s10545-010-9061-2","volume":"33","author":"SM Houten","year":"2010","unstructured":"Houten, S. M. & Wanders, R. J. A general introduction to the biochemistry of mitochondrial fatty acid beta-oxidation. J. Inherit. Metab. Dis. 33, 469\u2013477 (2010).","journal-title":"J. Inherit. Metab. Dis."},{"key":"1820_CR81","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1101\/gad.1987211","volume":"25","author":"K Zaugg","year":"2011","unstructured":"Zaugg, K. et al. Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress. Genes Dev. 25, 1041\u20131051 (2011).","journal-title":"Genes Dev."},{"key":"1820_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32101-w","volume":"13","author":"Y Tan","year":"2022","unstructured":"Tan, Y. et al. Metabolic reprogramming from glycolysis to fatty acid uptake and beta-oxidation in platinum-resistant cancer cells. Nat. Commun. 13, 4554 (2022).","journal-title":"Nat. Commun."},{"key":"1820_CR83","volume":"11","author":"R Lu","year":"2024","unstructured":"Lu, R. et al. Loss of OVOL2 in triple-negative breast cancer promotes fatty acid oxidation fueling stemness characteristics. Adv. Sci. 11, e2308945 (2024).","journal-title":"Adv. Sci."},{"key":"1820_CR84","volume":"120","author":"Y Huang","year":"2023","unstructured":"Huang, Y. et al. Nuclear VCP drives colorectal cancer progression by promoting fatty acid oxidation. Proc. Natl Acad. Sci. USA 120, e2221653120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1820_CR85","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1093\/nar\/gkg262","volume":"31","author":"N Camarero","year":"2003","unstructured":"Camarero, N., Nadal, A., Barrero, M. J., Haro, D. & Marrero, P. F. Histone deacetylase inhibitors stimulate mitochondrial HMG-CoA synthase gene expression via a promoter proximal Sp1 site. Nucleic Acids Res. 31, 1693\u20131703 (2003).","journal-title":"Nucleic Acids Res."},{"key":"1820_CR86","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.587189","volume":"11","author":"K Iizuka","year":"2020","unstructured":"Iizuka, K., Takao, K. & Yabe, D. ChREBP-mediated regulation of lipid metabolism: involvement of the gut microbiota, liver, and adipose tissue. Front. Endocrinol. 11, 587189 (2020).","journal-title":"Front. Endocrinol."},{"key":"1820_CR87","doi-asserted-by":"crossref","first-page":"6924","DOI":"10.1158\/0008-5472.CAN-16-1597","volume":"76","author":"HP Lin","year":"2016","unstructured":"Lin, H. P. et al. Destabilization of fatty acid synthase by acetylation inhibits de novo lipogenesis and tumor cell growth. Cancer Res. 76, 6924\u20136936 (2016).","journal-title":"Cancer Res."},{"key":"1820_CR88","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/s41588-022-01045-8","volume":"54","author":"X Lu","year":"2022","unstructured":"Lu, X. et al. HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancer. Nat. Genet. 54, 670\u2013683 (2022).","journal-title":"Nat. Genet."},{"key":"1820_CR89","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jare.2025.08.007","volume":"83","author":"Q Wang","year":"2026","unstructured":"Wang, Q. et al. Epigenetically silenced KAT2B suppresses de novo lipogenesis through destroying HDAC5\/LSD1 complex assembly in renal cell carcinoma. J. Adv. Res. 83, 677\u2013694 (2026).","journal-title":"J. Adv. Res."},{"key":"1820_CR90","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1706770","volume":"16","author":"M Franzo","year":"2025","unstructured":"Franzo, M. et al. Targeting lipogenesis promotes the synergistic effect of the selective HDAC6 inhibitor ITF3756 with bortezomib in colon cancer cells. Front. Pharmacol. 16, 1706770 (2025).","journal-title":"Front. Pharmacol."},{"key":"1820_CR91","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s12276-023-00971-9","volume":"55","author":"J Jin","year":"2023","unstructured":"Jin, J., Byun, J. K., Choi, Y. K. & Park, K. G. Targeting glutamine metabolism as a therapeutic strategy for cancer. Exp. Mol. Med. 55, 706\u2013715 (2023).","journal-title":"Exp. Mol. Med."},{"key":"1820_CR92","doi-asserted-by":"crossref","first-page":"19345","DOI":"10.1073\/pnas.0709747104","volume":"104","author":"RJ DeBerardinis","year":"2007","unstructured":"DeBerardinis, R. J. et al. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc. Natl Acad. Sci. USA. 104, 19345\u201319350 (2007).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"1820_CR93","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1111\/cas.15955","volume":"114","author":"Y Mezawa","year":"2023","unstructured":"Mezawa, Y. et al. Glutamine deficiency drives transforming growth factor-beta signaling activation that gives rise to myofibroblastic carcinoma-associated fibroblasts. Cancer Sci. 114, 4376\u20134387 (2023).","journal-title":"Cancer Sci."},{"key":"1820_CR94","volume":"7","author":"S Okabe","year":"2024","unstructured":"Okabe, S., Tanaka, Y., Moriyama, M. & Gotoh, A. Inhibition of glutaminolysis alone and in combination with HDAC inhibitor has anti-myeloma therapeutic effects. Cancer Drug Resist. 7, 25 (2024).","journal-title":"Cancer Drug Resist."},{"key":"1820_CR95","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.7150\/ijbs.69882","volume":"18","author":"T Wang","year":"2022","unstructured":"Wang, T. et al. Deacetylation of glutaminase by HDAC4 contributes to lung cancer tumorigenesis. Int. J. Biol. Sci. 18, 4452\u20134465 (2022).","journal-title":"Int. J. Biol. Sci."},{"key":"1820_CR96","volume":"25","author":"D Bai","year":"2025","unstructured":"Bai, D., Zhou, Y., Jing, L., Guo, C. & Yang, Q. Arginine metabolism in cancer biology and immunotherapy. Immune Netw. 25, e30 (2025).","journal-title":"Immune Netw."},{"key":"1820_CR97","volume":"8","author":"R Hou","year":"2017","unstructured":"Hou, R. et al. Identification of a novel UT-B urea transporter in human urothelial cancer. Front. Physiol. 8, 245 (2017).","journal-title":"Front. Physiol."},{"key":"1820_CR98","doi-asserted-by":"crossref","first-page":"11775","DOI":"10.7150\/thno.51655","volume":"10","author":"TC Chan","year":"2020","unstructured":"Chan, T. C. et al. SLC14A1 prevents oncometabolite accumulation and recruits HDAC1 to transrepress oncometabolite genes in urothelial carcinoma. Theranostics 10, 11775\u201311793 (2020).","journal-title":"Theranostics"}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01820-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01820-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01820-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:02:31Z","timestamp":1790982151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01820-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":98,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["1820"],"URL":"https:\/\/doi.org\/10.1038\/s12276-026-01820-1","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"30 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}